logo

For the Inventor, By the Inventor

Wilmington, NC, United States of America

Frederick D Sancilio

This inventor holds 25 USPTO granted patents, primarily in Pharmaceutical Formulations. Top assignees: Duramed Pharmaceuticals, Inc., Endeavor Pharmaceuticals, Applied Analytical Industries, Inc.. Active years: 1996-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederick D Sancilio. Retrieved from https://idiyas.com/inventor/frederick-d-sancilio-wpznef44

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 56.0

Average Co-Inventor Count = 4.3

ph-index = 13

Forward Citations = 646(Granted Patents)


Location History:

  • Wilimington, NC (US) (2003)
  • Wilmington, NC (US) (1996 - 2012)

Company Filing History:

goldMedal4 out of 14 
 
Duramed Pharmaceuticals, Inc.
 patents
silverMedal3 out of 3 
 
Endeavor Pharmaceuticals
 patents
bronzeMedal1 out of 11 
 
Applied Analytical Industries, Inc.
 patents
4. 1 out of 16 
 
Barr Laboratories, Inc.
 patents
5. 16 out of 834,513 
Other
 patents

Years Active: 1996-2012

Loading Chart...
Areas of Expertise:
Estrogenic Compounds
Pharmaceutical Compositions
Benzimidazole Compounds
Topical Formulations
Bioavailability Improvement
Granulated Formulations
Oral Liquid Compositions
Dry Blend Formulations
Unit Dosage Forms
FT-Raman Spectroscopy
25 patents (USPTO):Explore Patents
1. 8227454 - Estrogenic compounds, pharmaceutical compositions and formulations comprising the same (2012-07-24),
2. 7989436 - Estrogenic compounds and pharmaceutical formulations comprising the same (2011-08-02),
3. 7749989 - Estrogenic compounds, methods of using and methods of administering the same (2010-07-06),
4. 7459445 - Estrogenic compounds and topical pharmaceutical formulations of the same (2008-12-02),
5. 7179799 - (3) and (6) substituted estrogenic compounds (2007-02-20),
6. 6855703 - Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds (2005-02-15),
7. 6844334 - (3) and (6) substitued estrogenic compounds (2005-01-18),
8. 6780880 - FT-Raman spectroscopic measurement (2004-08-24),
9. 6706737 - Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same (2004-03-16),
10. 6667324 - Dry blend pharmaceutical formulations (2003-12-23),
11. 6667323 - Dry-blend pharmaceutical formulations (2003-12-23),
12. 6667321 - Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same (2003-12-23),
13. 6660726 - Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same (2003-12-09),
14. 6653329 - Granulated pharmaceutical formulations and methods for making the same (2003-11-25),
15. 6444689 - Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same (2002-09-03),

Title: The Legacy of Frederick D Sancilio: Innovator from Wilmington

Introduction: Frederick D Sancilio, a distinguished inventor hailing from Wilmington, NC, has made significant contributions to the field of innovation and patents.

Latest Patents: Frederick D Sancilio holds several patents in the healthcare and pharmaceutical sectors, focusing on novel drug delivery systems and formulations to improve patient outcomes.

Career Highlights: With a background in pharmaceutical sciences, Frederick D Sancilio has had a successful career marked by groundbreaking research and development in the medical field. His work has led to the creation of innovative solutions that have positively impacted the lives of many.

Collaborations: Throughout his career, Frederick D Sancilio has collaborated with leading researchers, scientists, and healthcare professionals to bring cutting-edge inventions to fruition. His collaborative efforts have resulted in the development of groundbreaking technologies that have reshaped the industry.

Conclusion: Frederick D Sancilio's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the field of healthcare and pharmaceuticals. His work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…